Pro Medicus (ASX:PME) reported Thursday that its earnings per diluted share in the fiscal first half rose to AU$0.4944 from AU$0.3461 per diluted share a year earlier.
Analysts polled by Visible Alpha were expecting EPS of AU$0.4957.
Revenue from contracts with customers for the six months to Dec. 31, 2024, was AU$97.2 million, up from AU$74.1 million in the same period a year earlier. Total revenue rose to AU$100.8 million from AU$76.3 million. Analysts surveyed by Visible Alpha expected total revenue of AU$99.7 million.
The board declared an interim dividend of AU$0.25 per share, up from the AU$0.18 per share in the previous reported period, payable on March 21 to shareholders on record as of Feb. 28.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。